Equibles does not estimate personal net worth.
Get an email with a short summary when Rapid Micro Biosystems, Inc. publishes a filing, an earnings call transcript or a press release.
Get RPID alertsSean Wirtjes is recorded as CFO at Rapid Micro Biosystems, Inc. (RPID). The newest filing on record that lists Sean Wirtjes as CFO at Rapid Micro Biosystems, Inc. (RPID) is dated April 8, 2026. The proxy statement of Rapid Micro Biosystems, Inc. reports total compensation of $1,589,310 for Sean Wirtjes in fiscal 2025, including a base salary of $465,700. Disclosed compensation is on record for 6 fiscal years. Sean Wirtjes has spoken on 14 earnings calls across 1 company, most recently for Rapid Micro Biosystems, Inc. on August 12, 2025. Rapid Micro Biosystems, Inc. is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Rapid Micro Biosystems, Inc. includes Robert G. Spignesi (CEO and Board Member), Robert Spignesi (CEO and Board Member), Kirk D. Malloy, Ph.D. (Chairman and Board Member) and 7 others.
“Total second quarter revenue of $7.3 million increased 10% compared to the $6.6 million we reported in Q2 2024. We placed 4 Growth Direct Systems and completed 2 validations in the second quarter and now stand at 169 cumulative global systems placed, including 148 fully validated systems.”
“I’ll begin my comments this morning with a review of our fourth quarter 2024 results and then discuss our first quarter and full year outlook for 2025. We will then open the call up for questions.”
“Consistent with our previous calls I'll begin my comments this morning with a review of our third quarter results followed by our current outlook for the full year 2024.”
“I'll start my comments today with a review of our second quarter results. I'll then review our third quarter and full year 2024 outlook, followed by additional color on the operational efficiency program we announced this morning.”
“I'll start my comments today with a review of our first quarter results and then discuss our second quarter and full year 2024 outlook. Q1 revenue increased 11% to $5.6 million compared to $5 million in Q1 2023.”
Start not stated–present
Last confirmed April 8, 2026
Medical Devices · Healthcare
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Rapid Micro Biosystems, Inc. (RPID) | Chief Financial Officer | $465,700 | $1,589,310 |
| 2024 | Rapid Micro Biosystems, Inc. (RPID) | Chief Financial Officer | $449,904 | $762,893 |
| 2023 | Rapid Micro Biosystems, Inc. (RPID) | Chief Financial Officer | $432,640 | $923,838 |
| 2022 | Rapid Micro Biosystems, Inc. (RPID) | Chief Financial Officer | $416,000 | $1,096,542 |
| 2021 | Rapid Micro Biosystems, Inc. (RPID) | Chief Financial Officer | $372,518 | $670,093 |
| 2020 | Rapid Micro Biosystems, Inc. (RPID) | Chief Financial Officer | $342,531 | $613,828 |
